Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Furtner

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Cancers|June 21, 2020
Sex-Specific Differences in Primary CNS LymphomaThomas Roetzer, Julia Furtner, Johanna Gesperger, et al.
Acta Neuropathologica|January 3, 2025
Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling methodSibylle Madlener, Natalia Stepien, Daniel Senfter, et al.
The Lancet. Oncology|October 30, 2025
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trialThorsten Fuereder, Javier Garde-Noguera, Juan José García-Mosquera, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0Antoine Verger, Nelleke Tolboom, Francesco Cicone, et al.
Nature Medicine|August 8, 2022
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trialRupert Bartsch, Anna Sophie Berghoff, Julia Furtner, et al.
Neuro-Oncology|August 11, 2022
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, et al.
Frontiers in Neurology|February 23, 2026
Automatic and standardized reporting of perioperative MRIs in patients with central nervous system tumorsDavid Bouget, Mathilde Gajda Faanes, Asgeir Store Jakola, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.
Nature Medicine|May 30, 2025
Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trialMatthias Preusser, Javier Garde-Noguera, Juan José García-Mosquera, et al.
The Lancet. Oncology|October 30, 2025
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trialRupert Bartsch, Maximilian Marhold, Javier Garde-Noguera, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Cancers|June 21, 2020
Sex-Specific Differences in Primary CNS LymphomaThomas Roetzer, Julia Furtner, Johanna Gesperger, et al.
Acta Neuropathologica|January 3, 2025
Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling methodSibylle Madlener, Natalia Stepien, Daniel Senfter, et al.
The Lancet. Oncology|October 30, 2025
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trialThorsten Fuereder, Javier Garde-Noguera, Juan José García-Mosquera, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 6, 2025
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0Antoine Verger, Nelleke Tolboom, Francesco Cicone, et al.
Nature Medicine|August 8, 2022
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trialRupert Bartsch, Anna Sophie Berghoff, Julia Furtner, et al.
Neuro-Oncology|August 11, 2022
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, et al.
Frontiers in Neurology|February 23, 2026
Automatic and standardized reporting of perioperative MRIs in patients with central nervous system tumorsDavid Bouget, Mathilde Gajda Faanes, Asgeir Store Jakola, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.
Nature Medicine|May 30, 2025
Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trialMatthias Preusser, Javier Garde-Noguera, Juan José García-Mosquera, et al.
The Lancet. Oncology|October 30, 2025
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trialRupert Bartsch, Maximilian Marhold, Javier Garde-Noguera, et al.
Pageof 15